CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,303,246 | -35.7% | 566,613 | +2.0% | 0.00% | -100.0% |
| Q2 2023 | $2,026,676 | +4.0% | 555,239 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $1,947,824 | +149158.5% | 545,624 | +19.2% | 0.00% | – |
| Q4 2022 | $1,305 | -99.9% | 457,667 | +0.8% | 0.00% | – |
| Q3 2022 | $1,013,000 | -39.2% | 454,172 | -32.1% | 0.00% | -100.0% |
| Q2 2022 | $1,666,000 | -54.0% | 668,634 | -9.9% | 0.00% | 0.0% |
| Q1 2022 | $3,620,000 | -62.3% | 741,903 | -12.6% | 0.00% | -66.7% |
| Q4 2021 | $9,606,000 | +257.2% | 849,343 | +360.1% | 0.00% | +200.0% |
| Q3 2021 | $2,689,000 | +186.1% | 184,612 | +128.7% | 0.00% | – |
| Q2 2021 | $940,000 | – | 80,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |